Contraindicated in:
Use Cautiously in:
CV: HF.
Derm: bullous pemphigoid, localized exfoliation, urticaria.
Endo: hypoglycemia.
GI: ↑ lipase, PANCREATITIS.
Metab: hypertriglyceridemia.
MS: arthralgia, RHABDOMYOLYSIS.
Resp: bronchial hyperreactivity.
Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS, ANGIOEDEMA, AND EXFOLIATIVE SKIN CONDITIONS).
(Generic available)
Absorption: 30% absorbed following oral administration.
Distribution: Extensively distributed to tissues.
Metabolism/Excretion: Minimally metabolized; primarily excreted in feces (80%) and urine (5%) as unchanged drug.
Half-life: >100 hr (due to saturable binding to DPP-4).
NDC Code*